{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T22:54:21Z","timestamp":1782255261711,"version":"3.54.5"},"reference-count":187,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"NIH","award":["5P20GM103432"],"award-info":[{"award-number":["5P20GM103432"]}]},{"DOI":"10.13039\/100000041","name":"American Diabetes Association","doi-asserted-by":"publisher","award":["7-13-BS-142-BR"],"award-info":[{"award-number":["7-13-BS-142-BR"]}],"id":[{"id":"10.13039\/100000041","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"NSFC","doi-asserted-by":"crossref","award":["1570225, 81522004"],"award-info":[{"award-number":["1570225, 81522004"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology &amp; Therapeutics"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1016\/j.pharmthera.2016.03.005","type":"journal-article","created":{"date-parts":[[2016,3,22]],"date-time":"2016-03-22T08:52:46Z","timestamp":1458636766000},"page":"52-66","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":98,"special_numbering":"C","title":["Epigenetics and obesity cardiomyopathy: From pathophysiology to prevention and management"],"prefix":"10.1016","volume":"161","author":[{"given":"Yingmei","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pharmthera.2016.03.005_bb0005","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1038\/463596b","article-title":"Project set to map marks on genome","volume":"463","author":"Abbott","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2016.03.005_bb0010","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s13148-015-0048-6","article-title":"An epigenetic map of age-associated autosomal loci in northern European families at high risk for the metabolic syndrome","volume":"7","author":"Ali","year":"2015","journal-title":"Clin Epigenetics"},{"key":"10.1016\/j.pharmthera.2016.03.005_bb0015","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1080\/15592294.2015.1029700","article-title":"Mendelian randomization supports causality between maternal hyperglycemia and epigenetic regulation of leptin gene in newborns","volume":"10","author":"Allard","year":"2015","journal-title":"Epigenetics"},{"key":"10.1016\/j.pharmthera.2016.03.005_bb0020","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1097\/00000441-200104000-00004","article-title":"Management of obesity cardiomyopathy","volume":"321","author":"Alpert","year":"2001","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.pharmthera.2016.03.005_bb0025","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/00000441-200104000-00003","article-title":"Obesity cardiomyopathy: pathophysiology and evolution of the clinical syndrome","volume":"321","author":"Alpert","year":"2001","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.pharmthera.2016.03.005_bb0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/HCR.0000000000000147","article-title":"Cardiac effects of obesity: pathophysiologic, clinical, and prognostic consequences\u2014a review","volume":"36","author":"Alpert","year":"2016","journal-title":"J Cardiopulm Rehabil Prev"},{"key":"10.1016\/j.pharmthera.2016.03.005_bb0035","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/454711a","article-title":"Moving AHEAD with an international human epigenome project","volume":"454","author":"American Association for Cancer Research Human Epigenome Task, F.","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2016.03.005_bb0040","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.drudis.2015.12.001","article-title":"Are epigenetic drugs for diabetes and obesity at our door step?","volume":"21","author":"Arguelles","year":"2016","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.pharmthera.2016.03.005_bb0045","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/nrendo.2015.25","article-title":"MicroRNA regulatory networks in human adipose tissue and obesity","volume":"11","author":"Arner","year":"2015","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.pharmthera.2016.03.005_bb0050","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1002\/oby.21111","article-title":"Epigenome-wide study identifies novel methylation loci associated with body mass index and waist circumference","volume":"23","author":"Aslibekyan","year":"2015","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.pharmthera.2016.03.005_bb0055","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1093\/eurheartj\/ehv089","article-title":"Lifetime risk: childhood obesity and cardiovascular risk","volume":"36","author":"Ayer","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.pharmthera.2016.03.005_bb0060","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.gene.2015.12.043","article-title":"Can all heritable biology really be reduced to a single dimension?","volume":"578","author":"Babbitt","year":"2016","journal-title":"Gene"},{"key":"10.1016\/j.pharmthera.2016.03.005_bb0065","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1136\/jech.58.2.114","article-title":"Developmental origins of adult health and disease","volume":"58","author":"Barker","year":"2004","journal-title":"J Epidemiol Community Health"},{"key":"10.1016\/j.pharmthera.2016.03.005_bb0070","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1097\/GRF.0b013e31829cb9ca","article-title":"The obstetric origins of health for a lifetime","volume":"56","author":"Barker","year":"2013","journal-title":"Clin Obstet Gynecol"},{"key":"10.1016\/j.pharmthera.2016.03.005_bb0075","doi-asserted-by":"crossref","first-page":"85","DOI":"10.2217\/epi.14.71","article-title":"Lifestyle, pregnancy and epigenetic effects","volume":"7","author":"Barua","year":"2015","journal-title":"Epigenomics"},{"key":"10.1016\/j.pharmthera.2016.03.005_bb0080","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1002\/cmdc.201300534","article-title":"Long noncoding RNAs: emerging stars in gene regulation, epigenetics and human disease","volume":"9","author":"Bhan","year":"2014","journal-title":"ChemMedChem"},{"key":"10.1016\/j.pharmthera.2016.03.005_bb0085","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1002\/humu.22472","article-title":"Distinct patterns of genetic variations in potential functional elements in long noncoding RNAs","volume":"35","author":"Bhartiya","year":"2014","journal-title":"Hum Mutat"},{"key":"10.1016\/j.pharmthera.2016.03.005_bb0090","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/S0140-6736(14)60892-8","article-title":"Body-mass index and risk of 22 specific cancers: a population-based cohort study of 5.24 million UK adults","volume":"384","author":"Bhaskaran","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.pharmthera.2016.03.005_bb0095","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1056\/NEJMp030053","article-title":"Diet, obesity, and cardiovascular risk","volume":"348","author":"Bonow","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pharmthera.2016.03.005_bb0100","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s40495-015-0018-x","article-title":"\u201cCurcumin, the King of Spices\u201d: epigenetic regulatory mechanisms in the prevention of cancer, neurological, and inflammatory diseases","volume":"1","author":"Boyanapalli","year":"2015","journal-title":"Curr Pharmacol Rep"},{"key":"10.1016\/j.pharmthera.2016.03.005_bb0105","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/path.4647","article-title":"The complexity of epigenetic diseases","volume":"238","author":"Brazel","year":"2016","journal-title":"J Pathol"},{"key":"10.1016\/j.pharmthera.2016.03.005_bb0110","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1002\/ajmg.a.37400","article-title":"Temple syndrome as a result of isolated hypomethylation of the 14q32 imprinted DLK1\/MEG3 region","volume":"170","author":"Briggs","year":"2016","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.pharmthera.2016.03.005_bb0115","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000001910","article-title":"Does an obesity paradox really exist after cardiovascular intervention?: a systematic review and meta-analysis of randomized controlled trials and Observational studies","volume":"94","author":"Bundhun","year":"2015","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.pharmthera.2016.03.005_bb0120","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1007\/s11033-014-3751-z","article-title":"Obesity and diabetes: from genetics to epigenetics","volume":"42","author":"Burgio","year":"2015","journal-title":"Mol Biol Rep"},{"key":"10.1016\/j.pharmthera.2016.03.005_bb0125","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.yjmcc.2015.10.028","article-title":"Genetics meets epigenetics: genetic variants that modulate noncoding RNA in cardiovascular diseases","volume":"89","author":"Calore","year":"2015","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.pharmthera.2016.03.005_bb0130","first-page":"3097","article-title":"Impact of epigenetics in the management of cardiovascular disease: a review","volume":"18","author":"Cao","year":"2014","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1016\/j.pharmthera.2016.03.005_bb0135","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/j.cell.2010.12.008","article-title":"Paternally induced transgenerational environmental reprogramming of metabolic gene expression in mammals","volume":"143","author":"Carone","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.pharmthera.2016.03.005_bb0140","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s13073-014-0060-z","article-title":"Epigenetics of discordant monozygotic twins: implications for disease","volume":"6","author":"Castillo-Fernandez","year":"2014","journal-title":"Genome Med"},{"key":"10.1016\/j.pharmthera.2016.03.005_bb0145","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.trsl.2014.05.001","article-title":"Obesity, metabolic dysfunction, and cardiac fibrosis: pathophysiological pathways, molecular mechanisms, and therapeutic opportunities","volume":"164","author":"Cavalera","year":"2014","journal-title":"Transl Res"},{"key":"10.1016\/j.pharmthera.2016.03.005_bb0150","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.cppeds.2015.03.003","article-title":"Early factors leading to later obesity: interactions of the microbiome, epigenome, and nutrition","volume":"45","author":"Chang","year":"2015","journal-title":"Curr Probl Pediatr Adolesc Health Care"},{"key":"10.1016\/j.pharmthera.2016.03.005_bb0155","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.tem.2015.08.008","article-title":"The genetics of Pediatric obesity","volume":"26","author":"Chesi","year":"2015","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.pharmthera.2016.03.005_bb0160","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1093\/carcin\/bgv015","article-title":"Concomitant mutation and epimutation of the MLH1 gene in a Lynch syndrome family","volume":"36","author":"Cini","year":"2015","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.pharmthera.2016.03.005_bb0165","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1056\/NEJMoa1502214","article-title":"FTO obesity variant circuitry and adipocyte Browning in humans","volume":"373","author":"Claussnitzer","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pharmthera.2016.03.005_bb0170","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1097\/MCO.0000000000000179","article-title":"Epigenetics of obesity: beyond the genome sequence","volume":"18","author":"Cordero","year":"2015","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"10.1016\/j.pharmthera.2016.03.005_bb0175","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.cell.2015.12.025","article-title":"Trim28 haploinsufficiency triggers Bi-stable epigenetic obesity","volume":"164","author":"Dalgaard","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.pharmthera.2016.03.005_bb0180","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1242\/jeb.107110","article-title":"Epigenetic linkage of aging, cancer and nutrition","volume":"218","author":"Daniel","year":"2015","journal-title":"J Exp Biol"},{"key":"10.1016\/j.pharmthera.2016.03.005_bb0185","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1161\/01.CIR.0000161369.71722.10","article-title":"Overweight in children and adolescents: pathophysiology, consequences, prevention, and treatment","volume":"111","author":"Daniels","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2016.03.005_bb0190","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1161\/CIRCULATIONAHA.109.192215","article-title":"American Heart Association childhood obesity research Summit: executive summary","volume":"119","author":"Daniels","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2016.03.005_bb0195","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/ijo.2015.170","article-title":"MicroRNAs as regulators of metabolic disease: pathophysiologic significance and emerging role as biomarkers and therapeutics","volume":"40","author":"Deiuliis","year":"2016","journal-title":"Int J Obes"},{"key":"10.1016\/j.pharmthera.2016.03.005_bb0200","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/eci.12406","article-title":"Biological embedding of early-life exposures and disease risk in humans: a role for DNA methylation","volume":"45","author":"Demetriou","year":"2015","journal-title":"Eur J Clin Investig"},{"key":"10.1016\/j.pharmthera.2016.03.005_bb0205","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/ijo.2015.13","article-title":"Epigenomics, gestational programming and risk of metabolic syndrome","volume":"39","author":"Desai","year":"2015","journal-title":"Int J Obes"},{"key":"10.1016\/j.pharmthera.2016.03.005_bb0210","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1016\/S0140-6736(13)62674-4","article-title":"DNA methylation and body-mass index: a genome-wide analysis","volume":"383","author":"Dick","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.pharmthera.2016.03.005_bb0215","doi-asserted-by":"crossref","first-page":"3464","DOI":"10.2337\/db14-1314","article-title":"Alterations of a cellular cholesterol metabolism network are a molecular feature of obesity-related type 2 diabetes and cardiovascular disease","volume":"64","author":"Ding","year":"2015","journal-title":"Diabetes"},{"key":"10.1016\/j.pharmthera.2016.03.005_bb0220","doi-asserted-by":"crossref","first-page":"652","DOI":"10.2174\/138161282004140213160930","article-title":"What fans the fire: insights into mechanisms of leptin in metabolic syndrome-associated heart diseases","volume":"20","author":"Dong","year":"2014","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.pharmthera.2016.03.005_bb0225","doi-asserted-by":"crossref","first-page":"53","DOI":"10.2337\/db15-0770","article-title":"The microRNA-29 family dictates the balance between homeostatic and pathological glucose handling in diabetes and obesity","volume":"65","author":"Dooley","year":"2016","journal-title":"Diabetes"},{"key":"10.1016\/j.pharmthera.2016.03.005_bb0230","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.2217\/epi.15.39","article-title":"Methyl-CpG-binding domain proteins: readers of the epigenome","volume":"7","author":"Du","year":"2015","journal-title":"Epigenomics"},{"key":"10.1016\/j.pharmthera.2016.03.005_bb0235","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.cmet.2013.06.004","article-title":"MicroRNAs and metabolism crosstalk in energy homeostasis","volume":"18","author":"Dumortier","year":"2013","journal-title":"Cell Metab"},{"key":"10.1016\/j.pharmthera.2016.03.005_bb0240","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1056\/NEJMcp0801652","article-title":"Clinical practice. Nonsurgical management of obesity in adults","volume":"358","author":"Eckel","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pharmthera.2016.03.005_bb0245","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s13148-015-0050-z","article-title":"Congenital imprinting disorders: EUCID.net \u2014 a network to decipher their aetiology and to improve the diagnostic and clinical care","volume":"7","author":"Eggermann","year":"2015","journal-title":"Clin Epigenetics"},{"key":"10.1016\/j.pharmthera.2016.03.005_bb0250","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/s13148-015-0143-8","article-title":"Imprinting disorders: a group of congenital disorders with overlapping patterns of molecular changes affecting imprinted loci","volume":"7","author":"Eggermann","year":"2015","journal-title":"Clin Epigenetics"},{"key":"10.1016\/j.pharmthera.2016.03.005_bb0255","doi-asserted-by":"crossref","DOI":"10.1038\/ctg.2016.1","article-title":"Genetic associations of obesity: the Fat-Mass and obesity-associated (FTO) gene","volume":"7","author":"Ehrlich","year":"2016","journal-title":"Clin Transl Gastroenterol"},{"key":"10.1016\/j.pharmthera.2016.03.005_bb0260","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.yjmcc.2015.07.012","article-title":"RNA (Epi)genetics in cardiovascular diseases","volume":"89","author":"Elia","year":"2015","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.pharmthera.2016.03.005_bb0265","doi-asserted-by":"crossref","first-page":"2924","DOI":"10.2337\/db14-0066","article-title":"Mitogen-activated protein kinase phosphatase 3 (MKP-3)-deficient mice are resistant to diet-induced obesity","volume":"63","author":"Feng","year":"2014","journal-title":"Diabetes"},{"key":"10.1016\/j.pharmthera.2016.03.005_bb0270","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1095\/biolreprod.114.122945","article-title":"The role of CCCTC-binding factor (CTCF) in genomic imprinting, development, and reproduction","volume":"91","author":"Franco","year":"2014","journal-title":"Biol Reprod"},{"key":"10.1016\/j.pharmthera.2016.03.005_bb0275","doi-asserted-by":"crossref","first-page":"21075","DOI":"10.1073\/pnas.1118922109","article-title":"Control of glucose homeostasis and insulin sensitivity by the Let-7 family of microRNAs","volume":"108","author":"Frost","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pharmthera.2016.03.005_bb0280","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1042\/BJ20100414","article-title":"Epigenetic changes and alteration of Fbn1 and Col3A1 gene expression under hyperglycaemic and hyperinsulinaemic conditions","volume":"432","author":"Gaikwad","year":"2010","journal-title":"Biochem J"},{"key":"10.1016\/j.pharmthera.2016.03.005_bb0285","doi-asserted-by":"crossref","first-page":"126","DOI":"10.3389\/fnins.2015.00126","article-title":"Developmental programming of hypothalamic neuronal circuits: impact on energy balance control","volume":"9","author":"Gali Ramamoorthy","year":"2015","journal-title":"Front Neurosci"},{"key":"10.1016\/j.pharmthera.2016.03.005_bb0290","doi-asserted-by":"crossref","first-page":"534320","DOI":"10.1155\/2015\/534320","article-title":"Differential role of leptin and adiponectin in cardiovascular system","volume":"2015","author":"Ghantous","year":"2015","journal-title":"Int J Endocrinol"},{"key":"10.1016\/j.pharmthera.2016.03.005_bb0295","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.2337\/db10-0979","article-title":"Epigenetic gene promoter methylation at birth is associated with child's later adiposity","volume":"60","author":"Godfrey","year":"2011","journal-title":"Diabetes"},{"key":"10.1016\/j.pharmthera.2016.03.005_bb0300","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1161\/01.CIR.0000161957.34198.2B","article-title":"Factor analysis of clustered cardiovascular risks in adolescence: obesity is the predominant correlate of risk among youth","volume":"111","author":"Goodman","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2016.03.005_bb0305","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/nrcardio.2015.71","article-title":"Epigenetic modifications and noncoding RNAs in cardiac hypertrophy and failure","volume":"12","author":"Greco","year":"2015","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.pharmthera.2016.03.005_bb0310","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.cell.2012.03.029","article-title":"A cardiac microRNA governs systemic energy homeostasis by regulation of MED13","volume":"149","author":"Grueter","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.pharmthera.2016.03.005_bb0315","article-title":"MicroRNA expression signature is altered in the cardiac remodeling induced by high fat diets","author":"Guedes","year":"2015","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.pharmthera.2016.03.005_bb0320","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1016\/j.bbadis.2013.03.013","article-title":"Adiponectin knockout accentuates high fat diet-induced obesity and cardiac dysfunction: role of autophagy","volume":"1832","author":"Guo","year":"2013","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.pharmthera.2016.03.005_bb0325","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.cjca.2014.08.004","article-title":"Obesity and the obesity paradox in heart failure","volume":"31","author":"Gupta","year":"2015","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.pharmthera.2016.03.005_bb0330","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1002\/emmm.201201553","article-title":"Alterations in cardiac DNA methylation in human dilated cardiomyopathy","volume":"5","author":"Haas","year":"2013","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.pharmthera.2016.03.005_bb0335","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1097\/MCO.0000000000000194","article-title":"Genetic and metabolic determinants of human epigenetic variation","volume":"18","author":"Haggarty","year":"2015","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"10.1016\/j.pharmthera.2016.03.005_bb0340","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.pharmthera.2015.03.003","article-title":"Epigenomes as therapeutic targets","volume":"151","author":"Hamm","year":"2015","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.pharmthera.2016.03.005_bb0345","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1161\/CIRCULATIONAHA.110.956839","article-title":"Epigenetic modifications: basic mechanisms and role in cardiovascular disease","volume":"123","author":"Handy","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2016.03.005_bb0350","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/MED.0b013e3283514e13","article-title":"What causes the insulin resistance underlying obesity?","volume":"19","author":"Hardy","year":"2012","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"10.1016\/j.pharmthera.2016.03.005_bb0355","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.semcdb.2015.09.012","article-title":"Refurbishing the germline epigenome: out with the old, in with the new","volume":"45","author":"Hogg","year":"2015","journal-title":"Semin Cell Dev Biol"},{"key":"10.1016\/j.pharmthera.2016.03.005_bb0360","first-page":"26","article-title":"Exercise and inflammation-related epigenetic modifications: focus on DNA methylation","volume":"21","author":"Horsburgh","year":"2015","journal-title":"Exerc Immunol Rev"},{"key":"10.1016\/j.pharmthera.2016.03.005_bb0365","doi-asserted-by":"crossref","first-page":"15538","DOI":"10.1073\/pnas.1412759111","article-title":"Obesity accelerates epigenetic aging of human liver","volume":"111","author":"Horvath","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pharmthera.2016.03.005_bb0370","doi-asserted-by":"crossref","first-page":"18858","DOI":"10.1038\/srep18858","article-title":"Both diet and gene mutation induced obesity affect oocyte quality in mice","volume":"6","author":"Hou","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.pharmthera.2016.03.005_bb0375","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s12881-015-0174-1","article-title":"Leptin and adiponectin DNA methylation levels in adipose tissues and blood cells are associated with BMI, waist girth and LDL-cholesterol levels in severely obese men and women","volume":"16","author":"Houde","year":"2015","journal-title":"BMC Med Genet"},{"key":"10.1016\/j.pharmthera.2016.03.005_bb0380","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jnutbio.2015.08.003","article-title":"Nutritional epigenetics with a focus on amino acids: implications for the development and treatment of metabolic syndrome","volume":"27","author":"Ji","year":"2016","journal-title":"J Nutr Biochem"},{"key":"10.1016\/j.pharmthera.2016.03.005_bb0385","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1530\/JME-14-0066","article-title":"Inhibition of HDAC3 promotes ligand-independent PPARgamma activation by protein acetylation","volume":"53","author":"Jiang","year":"2014","journal-title":"J Mol Endocrinol"},{"key":"10.1016\/j.pharmthera.2016.03.005_bb0390","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1017\/S0029665115004231","article-title":"Transgenerational epigenetic inheritance of diabetes risk as a consequence of early nutritional imbalances","volume":"75","author":"Jimenez-Chillaron","year":"2016","journal-title":"Proc Nutr Soc"},{"key":"10.1016\/j.pharmthera.2016.03.005_bb0395","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/ncb2211","article-title":"Obesity-induced overexpression of miRNA-143 inhibits insulin-stimulated AKT activation and impairs glucose metabolism","volume":"13","author":"Jordan","year":"2011","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.pharmthera.2016.03.005_bb0400","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.psyneuen.2013.11.004","article-title":"Rapid changes in histone deacetylases and inflammatory gene expression in expert meditators","volume":"40","author":"Kaliman","year":"2014","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.pharmthera.2016.03.005_bb0405","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.ijcard.2014.06.010","article-title":"DNA methylation inhibition: a novel therapeutic strategy for heart failure","volume":"176","author":"Kao","year":"2014","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.pharmthera.2016.03.005_bb0410","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/0002-9149(92)90739-L","article-title":"Cardiomyopathy of obesity: a clinicopathologic evaluation of 43 obese patients with heart failure","volume":"70","author":"Kasper","year":"1992","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.pharmthera.2016.03.005_bb0415","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1161\/CIRCRESAHA.116.303936","article-title":"Epigenetics and metabolism","volume":"116","author":"Keating","year":"2015","journal-title":"Circ Res"},{"key":"10.1016\/j.pharmthera.2016.03.005_bb0420","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1016\/S0140-6736(14)62367-9","article-title":"Prevalence of overweight and obesity in children and adults","volume":"384","author":"Keating","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.pharmthera.2016.03.005_bb0425","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1056\/NEJMoa020245","article-title":"Obesity and the risk of heart failure","volume":"347","author":"Kenchaiah","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pharmthera.2016.03.005_bb0430","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1161\/CIRCULATIONAHA.108.807289","article-title":"Body mass index and vigorous physical activity and the risk of heart failure among men","volume":"119","author":"Kenchaiah","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2016.03.005_bb0435","article-title":"Obesity and cardiovascular disease: friend or foe?","author":"Kim","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.pharmthera.2016.03.005_bb0440","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/s13148-015-0154-5","article-title":"The effects of long-term daily folic acid and vitamin B12 supplementation on genome-wide DNA methylation in elderly subjects","volume":"7","author":"Kok","year":"2015","journal-title":"Clin Epigenetics"},{"key":"10.1016\/j.pharmthera.2016.03.005_bb0445","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/nature11793","article-title":"Obesity-induced overexpression of miR-802 impairs glucose metabolism through silencing of Hnf1b","volume":"494","author":"Kornfeld","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2016.03.005_bb0450","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1097\/HJH.0000000000000645","article-title":"New developments in the pathogenesis of obesity-induced hypertension","volume":"33","author":"Kotsis","year":"2015","journal-title":"J Hypertens"},{"key":"10.1016\/j.pharmthera.2016.03.005_bb0455","doi-asserted-by":"crossref","first-page":"6807","DOI":"10.1073\/pnas.1408355111","article-title":"DNA methylation of BDNF as a biomarker of early-life adversity","volume":"112","author":"Kundakovic","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pharmthera.2016.03.005_bb0460","article-title":"DNA methylation analysis: choosing the right method","volume":"5","author":"Kurdyukov","year":"2016","journal-title":"Biology (Basel)"},{"key":"10.1016\/j.pharmthera.2016.03.005_bb0465","doi-asserted-by":"crossref","first-page":"4762","DOI":"10.1210\/en.2014-1565","article-title":"Inactivation of histone deacetylase 1 (HDAC1) but not HDAC2 is required for the glucocorticoid-dependent CCAAT\/enhancer-binding protein alpha (C\/EBPalpha) expression and preadipocyte differentiation","volume":"155","author":"Kuzmochka","year":"2014","journal-title":"Endocrinology"},{"key":"10.1016\/j.pharmthera.2016.03.005_bb0470","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1001\/archgenpsychiatry.2011.2287","article-title":"Genome-wide epigenetic regulation by early-life trauma","volume":"69","author":"Labonte","year":"2012","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pharmthera.2016.03.005_bb0475","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/j.clp.2014.08.006","article-title":"Fetal programming, epigenetics, and adult onset disease","volume":"41","author":"Lane","year":"2014","journal-title":"Clin Perinatol"},{"key":"10.1016\/j.pharmthera.2016.03.005_bb0480","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.pneurobio.2015.05.002","article-title":"The epigenetics of aging and neurodegeneration","volume":"131","author":"Lardenoije","year":"2015","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.pharmthera.2016.03.005_bb0485","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.phrs.2012.09.003","article-title":"Autophagy, signaling and obesity","volume":"66","author":"Lavallard","year":"2012","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.pharmthera.2016.03.005_bb0490","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/j.jacc.2014.01.022","article-title":"Obesity and cardiovascular diseases: implications regarding fitness, fatness, and severity in the obesity paradox","volume":"63","author":"Lavie","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pharmthera.2016.03.005_bb0495","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.pcad.2015.12.003","article-title":"Update on obesity and obesity paradox in heart failure","volume":"58","author":"Lavie","year":"2016","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.pharmthera.2016.03.005_bb0500","doi-asserted-by":"crossref","first-page":"9492","DOI":"10.3390\/nu7115467","article-title":"Impact of maternal diet on the epigenome during In utero life and the developmental programming of diseases in childhood and adulthood","volume":"7","author":"Lee","year":"2015","journal-title":"Nutrients"},{"key":"10.1016\/j.pharmthera.2016.03.005_bb0505","doi-asserted-by":"crossref","first-page":"3801","DOI":"10.1093\/hmg\/ddu093","article-title":"Histone deacetylase 3 modulates Tbx5 activity to regulate early cardiogenesis","volume":"23","author":"Lewandowski","year":"2014","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.pharmthera.2016.03.005_bb0510","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.1038\/oby.2012.106","article-title":"Short-term lenalidomide (Revlimid) administration ameliorates cardiomyocyte contractile dysfunction in ob\/ob obese mice","volume":"20","author":"Li","year":"2012","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.pharmthera.2016.03.005_bb0515","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.bbadis.2014.06.027","article-title":"Antioxidant catalase rescues against high fat diet-induced cardiac dysfunction via an IKKbeta-AMPK-dependent regulation of autophagy","volume":"1852","author":"Liang","year":"2015","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.pharmthera.2016.03.005_bb0520","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000001981","article-title":"Maternal blood pressure during pregnancy and early childhood blood pressures in the offspring: the GUSTO birth cohort study","volume":"94","author":"Lim","year":"2015","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.pharmthera.2016.03.005_bb0525","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.envpol.2015.08.016","article-title":"Transgenerational inheritance of heart disorders caused by paternal bisphenol A exposure","volume":"206","author":"Lombo","year":"2015","journal-title":"Environ Pollut"},{"key":"10.1016\/j.pharmthera.2016.03.005_bb0530","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.bbacli.2015.03.005","article-title":"Lipoprotein particles and size, total and high molecular weight adiponectin, and leptin in relation to incident coronary heart disease among severely obese postmenopausal women: the Women's Health Initiative Observational study","volume":"3","author":"Mackey","year":"2015","journal-title":"BBA Clin"},{"key":"10.1016\/j.pharmthera.2016.03.005_bb0535","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.tcm.2014.09.005","article-title":"Impact of obesity on cardiac metabolism, fibrosis, and function","volume":"25","author":"Mahajan","year":"2015","journal-title":"Trends Cardiovasc Med"},{"key":"10.1016\/j.pharmthera.2016.03.005_bb0540","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000368425","article-title":"SH2B1 CpG-SNP is associated with body weight reduction in obese subjects following a dietary restriction program","volume":"66","author":"Mansego","year":"2015","journal-title":"Ann Nutr Metab"},{"key":"10.1016\/j.pharmthera.2016.03.005_bb0545","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s10741-015-9483-x","article-title":"Epigenetics of the failing heart","volume":"20","author":"Marin-Garcia","year":"2015","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.pharmthera.2016.03.005_bb0550","doi-asserted-by":"crossref","first-page":"3595","DOI":"10.1096\/fj.14-260323","article-title":"Noncoding RNAs, cytokines, and inflammation-related diseases","volume":"29","author":"Marques-Rocha","year":"2015","journal-title":"FASEB J"},{"key":"10.1016\/j.pharmthera.2016.03.005_bb0555","doi-asserted-by":"crossref","first-page":"46","DOI":"10.2741\/s424","article-title":"Epigenetic crosstalk: a molecular language in human metabolic disorders","volume":"7","author":"Martinez-Jimenez","year":"2015","journal-title":"Front Biosci (Schol Ed)"},{"key":"10.1016\/j.pharmthera.2016.03.005_bb0560","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1002\/oby.21080","article-title":"Relationship of thoracic fat depots with coronary atherosclerosis and circulating inflammatory biomarkers","volume":"23","author":"Maurovich-Horvat","year":"2015","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.pharmthera.2016.03.005_bb0565","doi-asserted-by":"crossref","first-page":"R519","DOI":"10.1152\/ajpregu.00253.2013","article-title":"Consuming a Western diet for two weeks suppresses fetal genes in mouse hearts","volume":"306","author":"Medford","year":"2014","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1016\/j.pharmthera.2016.03.005_bb0570","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1101\/gad.234294.113","article-title":"DNA methylation dynamics during epigenetic reprogramming in the germline and preimplantation embryos","volume":"28","author":"Messerschmidt","year":"2014","journal-title":"Genes Dev"},{"key":"10.1016\/j.pharmthera.2016.03.005_bb0930","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1002\/em.20596","article-title":"Differential methylation of CpG sites in two isoforms of myosin binding protein C, an important hypertrophic cardiomyopathy gene","volume":"52","author":"Meurs","year":"2010","journal-title":"Environ Mol Mutagen"},{"key":"10.1016\/j.pharmthera.2016.03.005_bb0575","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.3109\/07420528.2012.719967","article-title":"CLOCK, PER2 and BMAL1 DNA methylation: association with obesity and metabolic syndrome characteristics and monounsaturated fat intake","volume":"29","author":"Milagro","year":"2012","journal-title":"Chronobiol Int"},{"key":"10.1016\/j.pharmthera.2016.03.005_bb0935","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1101\/gad.1563807","article-title":"Histone deacetylases 1 and 2 redundantly regulate cardiac morphogenesis, growth, and contractility","volume":"21","author":"Montgomery","year":"2007","journal-title":"Genes Dev"},{"key":"10.1016\/j.pharmthera.2016.03.005_bb0580","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/nrendo.2014.124","article-title":"Obesity: global trends in the prevalence of overweight and obesity","volume":"10","author":"Morgen","year":"2014","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.pharmthera.2016.03.005_bb0585","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1096\/fj.15-274274","article-title":"Paternal long-term exercise programs offspring for low energy expenditure and increased risk for obesity in mice","volume":"30","author":"Murashov","year":"2016","journal-title":"FASEB J"},{"key":"10.1016\/j.pharmthera.2016.03.005_bb0590","first-page":"324","article-title":"MicroRNA-192* impairs adipocyte triglyceride storage","volume":"1864","author":"Mysore","year":"2016","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.pharmthera.2016.03.005_bb0595","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/nrcardio.2011.86","article-title":"Childhood obesity and cardiovascular disease: links and prevention strategies","volume":"8","author":"Nadeau","year":"2011","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.pharmthera.2016.03.005_bb0600","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.2174\/092986709788186110","article-title":"Pharmacotherapy of obesity \u2014 benefit, bias and hyperbole","volume":"16","author":"Nair","year":"2009","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.pharmthera.2016.03.005_bb0605","article-title":"The role of obesity in atrial fibrillation","author":"Nalliah","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.pharmthera.2016.03.005_bb0610","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.cmet.2015.05.011","article-title":"Understanding the cellular and molecular mechanisms of physical activity-induced health benefits","volume":"22","author":"Neufer","year":"2015","journal-title":"Cell Metab"},{"key":"10.1016\/j.pharmthera.2016.03.005_bb0615","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/S0140-6736(14)60460-8","article-title":"Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the global burden of disease study 2013","volume":"384","author":"Ng","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.pharmthera.2016.03.005_bb0620","doi-asserted-by":"crossref","first-page":"E1491","DOI":"10.1210\/jc.2015-3204","article-title":"Epigenetic alterations in human liver from subjects with type 2 diabetes in Parallel with reduced folate levels","volume":"100","author":"Nilsson","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pharmthera.2016.03.005_bb0625","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s13148-015-0073-5","article-title":"Genome-wide blood DNA methylation alterations at regulatory elements and heterochromatic regions in monozygotic twins discordant for obesity and liver fat","volume":"7","author":"Ollikainen","year":"2015","journal-title":"Clin Epigenetics"},{"key":"10.1016\/j.pharmthera.2016.03.005_bb0630","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/nrendo.2014.42","article-title":"Obesity. Looking at the epigenetic link between obesity and its consequences\u2014the promise of EWAS","volume":"10","author":"Osorio","year":"2014","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.pharmthera.2016.03.005_bb0635","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1016\/j.cell.2014.11.005","article-title":"Paternal diet defines offspring chromatin state and intergenerational obesity","volume":"159","author":"Ost","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.pharmthera.2016.03.005_bb0640","article-title":"Super-enhancer lncs to cardiovascular development and disease","author":"Ounzain","year":"2015","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.pharmthera.2016.03.005_bb0645","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s11897-007-0016-3","article-title":"Is there a cardiomyopathy of obesity?","volume":"4","author":"Owan","year":"2007","journal-title":"Curr Heart Fail Rep"},{"key":"10.1016\/j.pharmthera.2016.03.005_bb0650","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/nrendo.2014.218","article-title":"Epigenetics and metabolism in 2014: metabolic programming\u2013knowns, unknowns and possibilities","volume":"11","author":"Ozanne","year":"2015","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.pharmthera.2016.03.005_bb0655","doi-asserted-by":"crossref","first-page":"937","DOI":"10.2217\/epi.15.45","article-title":"HIF3A association with adiposity: the story begins before birth","volume":"7","author":"Pan","year":"2015","journal-title":"Epigenomics"},{"key":"10.1016\/j.pharmthera.2016.03.005_bb0660","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1007\/s11892-015-0677-3","article-title":"Epigenetics and cardiovascular disease in diabetes","volume":"15","author":"Pasquier","year":"2015","journal-title":"Curr Diab Rep"},{"key":"10.1016\/j.pharmthera.2016.03.005_bb0665","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/s13148-015-0144-7","article-title":"Influences of diet and the gut microbiome on epigenetic modulation in cancer and other diseases","volume":"7","author":"Paul","year":"2015","journal-title":"Clin Epigenetics"},{"key":"10.1016\/j.pharmthera.2016.03.005_bb0670","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1161\/01.ATV.0000216787.85457.f3","article-title":"Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss","volume":"26","author":"Poirier","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.pharmthera.2016.03.005_bb0675","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1038\/nbt.1685","article-title":"Epigenetic modifications and human disease","volume":"28","author":"Portela","year":"2010","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.pharmthera.2016.03.005_bb0680","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1002\/oby.21216","article-title":"Obesity paradox: origin and best way to assess severity in patients with systolic HF","volume":"23","author":"Pozzo","year":"2015","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.pharmthera.2016.03.005_bb0685","doi-asserted-by":"crossref","first-page":"935","DOI":"10.3390\/genes6040935","article-title":"Epigenetic therapy for Solid Tumors: Highlighting the impact of tumor hypoxia","volume":"6","author":"Ramachandran","year":"2015","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.pharmthera.2016.03.005_bb0690","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1007\/s00439-015-1599-5","article-title":"Scrutinizing the FTO locus: compelling evidence for a complex, long-range regulatory context","volume":"134","author":"Rask-Andersen","year":"2015","journal-title":"Hum Genet"},{"key":"10.1016\/j.pharmthera.2016.03.005_bb0695","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1038\/ki.2015.148","article-title":"Recent developments in epigenetics of acute and chronic kidney diseases","volume":"88","author":"Reddy","year":"2015","journal-title":"Kidney Int"},{"key":"10.1016\/j.pharmthera.2016.03.005_bb0700","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.bcp.2014.12.006","article-title":"The insulin-like growth factor I system: physiological and pathophysiological implication in cardiovascular diseases associated with metabolic syndrome","volume":"93","author":"Ren","year":"2015","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.pharmthera.2016.03.005_bb0705","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1038\/oby.2009.8","article-title":"Cardiac health in women with metabolic syndrome: clinical aspects and pathophysiology","volume":"17","author":"Ren","year":"2009","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.pharmthera.2016.03.005_bb0710","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.bbadis.2014.11.002","article-title":"Emerging potential of therapeutic targeting of autophagy and protein quality control in the management of cardiometabolic diseases","volume":"1852","author":"Ren","year":"2015","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.pharmthera.2016.03.005_bb0715","first-page":"341","article-title":"Low birth weight and obesity: causal or casual association?","volume":"33","author":"Ribeiro","year":"2015","journal-title":"Rev Paul Pediatr"},{"key":"10.1016\/j.pharmthera.2016.03.005_bb0720","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1161\/CIRCRESAHA.117.304156","article-title":"Lncing epigenetic control of transcription to cardiovascular development and disease","volume":"117","author":"Rizki","year":"2015","journal-title":"Circ Res"},{"key":"10.1016\/j.pharmthera.2016.03.005_bb0725","first-page":"3792","article-title":"Impact of age, BMI and HbA1c levels on the genome-wide DNA methylation and mRNA expression patterns in human adipose tissue and identification of epigenetic biomarkers in blood","volume":"24","author":"Ronn","year":"2015","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.pharmthera.2016.03.005_bb0730","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/nrm3313","article-title":"MicroRNAs in metabolism and metabolic disorders","volume":"13","author":"Rottiers","year":"2012","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.pharmthera.2016.03.005_bb0735","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/nrendo.2014.198","article-title":"Obesity: obesity turns the hepatic epigenetic clock forward","volume":"11","author":"Sargent","year":"2015","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.pharmthera.2016.03.005_bb0740","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.tips.2015.02.005","article-title":"Epigenetic-related therapeutic challenges in cardiovascular disease","volume":"36","author":"Schiano","year":"2015","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.pharmthera.2016.03.005_bb0745","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1161\/ATVBAHA.115.305041","article-title":"Chromatin modifications associated with diabetes and obesity","volume":"35","author":"Schones","year":"2015","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.pharmthera.2016.03.005_bb0750","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1016\/j.amjcard.2015.02.024","article-title":"Meta-analysis of the relation of body mass index to all-cause and cardiovascular mortality and hospitalization in patients with chronic heart failure","volume":"115","author":"Sharma","year":"2015","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.pharmthera.2016.03.005_bb0755","doi-asserted-by":"crossref","first-page":"5282","DOI":"10.1038\/srep05282","article-title":"Epigenetic modification of the leptin promoter in diet-induced obese mice and the effects of N\u22123 polyunsaturated fatty acids","volume":"4","author":"Shen","year":"2014","journal-title":"Sci Rep"},{"key":"10.1016\/j.pharmthera.2016.03.005_bb0760","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta19430","article-title":"The use of measures of obesity in childhood for predicting obesity and the development of obesity-related diseases in adulthood: a systematic review and meta-analysis","volume":"19","author":"Simmonds","year":"2015","journal-title":"Health Technol Assess"},{"key":"10.1016\/j.pharmthera.2016.03.005_bb0765","doi-asserted-by":"crossref","first-page":"15170","DOI":"10.1523\/JNEUROSCI.4349-14.2015","article-title":"Changes in methionine metabolism and histone H3 trimethylation are linked to mitochondrial defects in multiple sclerosis","volume":"35","author":"Singhal","year":"2015","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2016.03.005_bb0770","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.amjcard.2006.02.044","article-title":"Relation of increase in adiposity to increase in left ventricular mass from childhood to young adulthood","volume":"98","author":"Sivanandam","year":"2006","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.pharmthera.2016.03.005_bb0775","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1038\/nrg933","article-title":"Conrad Hal Waddington: the last Renaissance biologist?","volume":"3","author":"Slack","year":"2002","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.pharmthera.2016.03.005_bb0780","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.pbiomolbio.2015.02.008","article-title":"Epigenetic inheritance and evolution: a paternal perspective on dietary influences","volume":"118","author":"Soubry","year":"2015","journal-title":"Prog Biophys Mol Biol"},{"key":"10.1016\/j.pharmthera.2016.03.005_bb0785","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/j.jacc.2015.06.1328","article-title":"The CardioMetabolic health alliance: working toward a new care model for the metabolic syndrome","volume":"66","author":"Sperling","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pharmthera.2016.03.005_bb0790","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.semcdb.2015.04.007","article-title":"Transgenerational inheritance of metabolic disease","volume":"43","author":"Stegemann","year":"2015","journal-title":"Semin Cell Dev Biol"},{"key":"10.1016\/j.pharmthera.2016.03.005_bb0795","doi-asserted-by":"crossref","DOI":"10.1002\/oby.21239","article-title":"Smoking and reverse causation create an obesity paradox in cardiovascular disease","author":"Stokes","year":"2015","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.pharmthera.2016.03.005_bb0800","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.yjmcc.2015.11.034","article-title":"High-fat diet increases vulnerability to atrial arrhythmia by conduction disturbance via miR-27b","volume":"90","author":"Takahashi","year":"2016","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.pharmthera.2016.03.005_bb0805","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.gene.2015.07.068","article-title":"Circulating microRNAs in obese and lean heart failure patients: A case\u2013control study with computational target prediction analysis","volume":"574","author":"Thome","year":"2015","journal-title":"Gene"},{"key":"10.1016\/j.pharmthera.2016.03.005_bb0810","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1017\/S2040174415001300","article-title":"The programming of cardiovascular disease","volume":"6","author":"Thornburg","year":"2015","journal-title":"J Dev Orig Health Dis"},{"key":"10.1016\/j.pharmthera.2016.03.005_bb0815","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/nature10112","article-title":"MicroRNAs 103 and 107 regulate insulin sensitivity","volume":"474","author":"Trajkovski","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2016.03.005_bb0820","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s40246-015-0041-3","article-title":"Epigenetic inheritance and the missing heritability","volume":"9","author":"Trerotola","year":"2015","journal-title":"Hum Genomics"},{"key":"10.1016\/j.pharmthera.2016.03.005_bb0825","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1111\/1440-1681.12158","article-title":"Inhibition of DNA methylation attenuates low-dose cadmium-induced cardiac contractile and intracellular Ca(2+) anomalies","volume":"40","author":"Turdi","year":"2013","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1016\/j.pharmthera.2016.03.005_bb0830","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.mam.2012.08.001","article-title":"Cardiovascular epigenetics: from DNA methylation to microRNAs","volume":"34","author":"Udali","year":"2013","journal-title":"Mol Asp Med"},{"key":"10.1016\/j.pharmthera.2016.03.005_bb0835","first-page":"37","article-title":"In utero alcohol exposure, epigenetic changes, and their consequences","volume":"35","author":"Ungerer","year":"2013","journal-title":"Alcohol Res"},{"key":"10.1016\/j.pharmthera.2016.03.005_bb0840","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/s13148-015-0130-0","article-title":"Epidemiologic evidence for association between adverse environmental exposures in early life and epigenetic variation: a potential link to disease susceptibility?","volume":"7","author":"Vaiserman","year":"2015","journal-title":"Clin Epigenetics"},{"key":"10.1016\/j.pharmthera.2016.03.005_bb0845","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1007\/s11892-015-0624-3","article-title":"Early-life exposure to substance abuse and risk of type 2 diabetes in adulthood","volume":"15","author":"Vaiserman","year":"2015","journal-title":"Curr Diab Rep"},{"key":"10.1016\/j.pharmthera.2016.03.005_bb0850","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/ijo.2014.34","article-title":"Epigenetics and human obesity","volume":"39","author":"van Dijk","year":"2015","journal-title":"Int J Obes"},{"key":"10.1016\/j.pharmthera.2016.03.005_bb0855","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/S0140-6736(13)62076-0","article-title":"Overweight, obesity, and outcomes: fat mass and beyond","volume":"383","author":"Van Gaal","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.pharmthera.2016.03.005_bb0860","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s13148-016-0170-0","article-title":"Epigenetic associations in relation to cardiovascular prevention and therapeutics","volume":"8","author":"Voelter-Mahlknecht","year":"2016","journal-title":"Clin Epigenetics"},{"key":"10.1016\/j.pharmthera.2016.03.005_bb0865","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/nyas.12778","article-title":"Early-life influences on obesity: from preconception to adolescence","volume":"1347","author":"Wahlqvist","year":"2015","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.pharmthera.2016.03.005_bb0870","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1089\/ars.2011.4381","article-title":"Nutrition, epigenetics, and metabolic syndrome","volume":"17","author":"Wang","year":"2012","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.pharmthera.2016.03.005_bb0875","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.cjca.2012.10.023","article-title":"Epigenetics and cardiovascular disease","volume":"29","author":"Webster","year":"2013","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.pharmthera.2016.03.005_bb0880","article-title":"Current perspectives on long-term pharmacotherapy for obesity","author":"Wharton","year":"2015","journal-title":"Can J Diabetes"},{"key":"10.1016\/j.pharmthera.2016.03.005_bb0885","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/s11033-014-3727-z","article-title":"Epigenetics in the development, modification, and prevention of cardiovascular disease","volume":"42","author":"Whayne","year":"2015","journal-title":"Mol Biol Rep"},{"key":"10.1016\/j.pharmthera.2016.03.005_bb0890","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20150155","article-title":"Regulatory networks of non-coding RNAs in brown\/beige adipogenesis","volume":"35","author":"Xu","year":"2015","journal-title":"Biosci Rep"},{"key":"10.1016\/j.pharmthera.2016.03.005_bb0895","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1161\/ATVBAHA.115.305043","article-title":"Epigenetics in the vascular endothelium: looking from a different perspective in the epigenomics era","volume":"35","author":"Yan","year":"2015","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.pharmthera.2016.03.005_bb0900","doi-asserted-by":"crossref","first-page":"283","DOI":"10.2217\/epi.14.84","article-title":"Oxidative stress and DNA methylation regulation in the metabolic syndrome","volume":"7","author":"Yara","year":"2015","journal-title":"Epigenomics"},{"key":"10.1016\/j.pharmthera.2016.03.005_bb0905","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1161\/HYPERTENSIONAHA.110.164178","article-title":"Role of cardiac steatosis and lipotoxicity in obesity cardiomyopathy","volume":"57","author":"Zhang","year":"2011","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2016.03.005_bb0910","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1161\/CIRCULATIONAHA.113.008115","article-title":"Targeting autophagy for the therapeutic application of histone deacetylase inhibitors in ischemia\/reperfusion heart injury","volume":"129","author":"Zhang","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2016.03.005_bb0915","first-page":"9","article-title":"Fatty acid binding protein 3 (fabp3) is associated with insulin, lipids and cardiovascular phenotypes of the metabolic syndrome through epigenetic modifications in a Northern European family population","volume":"6","author":"Zhang","year":"2013","journal-title":"BMC Med Genet"},{"key":"10.1016\/j.pharmthera.2016.03.005_bb0920","doi-asserted-by":"crossref","first-page":"939","DOI":"10.4161\/auto.24398","article-title":"MTOR overactivation and interrupted autophagy flux in obese hearts: a dicey assembly?","volume":"9","author":"Zhang","year":"2013","journal-title":"Autophagy"},{"key":"10.1016\/j.pharmthera.2016.03.005_bb0925","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1161\/HYPERTENSIONAHA.111.181867","article-title":"Insulin-like growth factor 1 alleviates high-fat diet-induced myocardial contractile dysfunction: role of insulin signaling and mitochondrial function","volume":"59","author":"Zhang","year":"2012","journal-title":"Hypertension"}],"container-title":["Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725816300134?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725816300134?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,15]],"date-time":"2024-06-15T05:56:06Z","timestamp":1718430966000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163725816300134"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":187,"alternative-id":["S0163725816300134"],"URL":"https:\/\/doi.org\/10.1016\/j.pharmthera.2016.03.005","relation":{},"ISSN":["0163-7258"],"issn-type":[{"value":"0163-7258","type":"print"}],"subject":[],"published":{"date-parts":[[2016,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epigenetics and obesity cardiomyopathy: From pathophysiology to prevention and management","name":"articletitle","label":"Article Title"},{"value":"Pharmacology & Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharmthera.2016.03.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}